GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » HPC Biosciences Ltd (BOM:535217) » Definitions » Change In Receivables

HPC Biosciences (BOM:535217) Change In Receivables : ₹0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2013. Start your Free Trial

What is HPC Biosciences Change In Receivables?

HPC Biosciences's change in receivables for the quarter that ended in Mar. 2023 was ₹3.00 Mil. It means HPC Biosciences's Accounts Receivable declined by ₹3.00 Mil from Sep. 2022 to Mar. 2023 .

HPC Biosciences's change in receivables for the fiscal year that ended in Mar. 2023 was ₹0.00 Mil. It means HPC Biosciences's Accounts Receivable stayed the same from Mar. 2022 to Mar. 2023 .

HPC Biosciences's Accounts Receivable for the quarter that ended in Mar. 2023 was ₹57.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. HPC Biosciences's Days Sales Outstanding for the six months ended in Mar. 2023 was 9,589.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. HPC Biosciences's liquidation value for the six months ended in Mar. 2023 was ₹45.07 Mil.


HPC Biosciences Change In Receivables Historical Data

The historical data trend for HPC Biosciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPC Biosciences Change In Receivables Chart

HPC Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.33 -1.29 -2.78 - -

HPC Biosciences Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 - - -3.00 3.00

HPC Biosciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPC Biosciences  (BOM:535217) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

HPC Biosciences's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=57.01/1.085*91
=9,589.24

2. In Ben Graham's calculation of liquidation value, HPC Biosciences's accounts receivable are only considered to be worth 75% of book value:

HPC Biosciences's liquidation value for the quarter that ended in Mar. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4.939-2.628+0.75 * 57.01+0.5 * 0
=45.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPC Biosciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of HPC Biosciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


HPC Biosciences (BOM:535217) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 22, Pooja Complex, Office Number 109, First Floor, Veer Savarkar Block, Shakarpur, Delhi, IND, 110092
HPC Biosciences Ltd is an Indian-based company that operates in the agricultural industry. The business activity of the group includes producing and marketing agricultural products, including wheat, rice, pulses, and vegetables. Geographically operations are performed through the regions of India, and it derives revenue from the sale of products.

HPC Biosciences (BOM:535217) Headlines

No Headlines